Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4733
Source ID: NCT01289990
Associated Drug: Bi 10773
Title: Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01289990/results
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: BI 10773|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo|DRUG: BI 10773|DRUG: Placebo|DRUG: Placebo|DRUG: BI 10773|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo|DRUG: BI 10773|DRUG: BI 10773|DRUG: BI 10773|DRUG: Placebo|DRUG: BI 10773|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo|DRUG: Sitagliptin 100mg|DRUG: BI 10773|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo|DRUG: Placebo
Outcome Measures: Primary: Changes From Baseline in Glycosylated Haemoglobin (HbA1c) (%) After 52 Weeks of Treatment, Change from baseline in HbA1c after 52 weeks, Baseline and 52 weeks|Changes From Baseline in HbA1c (%) After 76 Weeks of Treatment, Change from baseline in HbA1c after 76 weeks, Baseline and 76 weeks | Secondary: HbA1c (%) Changes From Baseline After 76 Weeks of Treatment, Change from baseline in HbA1c (%) after 76 weeks using MMRM approach, Baseline and 76 weeks|Systolic Blood Pressure: Change From Baseline After 52 Weeks of Treatment, Systolic blood pressure - change from baseline after 52 weeks of treatment, Baseline and 52 weeks|Systolic Blood Pressure: Change From Baseline After 76 Weeks of Treatment, Systolic blood pressure - change from baseline after 76 weeks of treatment, Baseline and 76 weeks|Diastolic Blood Pressure: Change From Baseline After 52 Weeks of Treatment, Diastolic blood pressure - change from baseline after 52 weeks of treatment, Baseline and 52 weeks|Diastolic Blood Pressure: Change From Baseline After 76 Weeks of Treatment, Diastolic blood pressure - change from baseline after 76 weeks of treatment, Baseline and 76 weeks|Body Weight (kg) Change From Baseline After 52 Weeks of Treatment, Body Weight (kg) - Change From Baseline After 52 Weeks of Treatment, Baseline and 52 weeks|Body Weight (kg) Change From Baseline After 76 Weeks of Treatment, Body Weight (kg) - Change From Baseline After 76 Weeks of Treatment, Baseline and 76 weeks|Waist Circumference (cm) Change From Baseline After 52 Weeks of Treatment, Waist circumference (cm) - change from baseline after 52 weeks of treatment, Baseline and 52 weeks|Waist Circumference (cm) Change From Baseline After 76 Weeks of Treatment, Waist circumference (cm) - change from baseline after 76 weeks of treatment, Baseline and 76 weeks|Fasting Plasma Glucose Change From Baseline After 52 Weeks of Treatment, Fasting plasma glucose - change from baseline after 52 weeks of treatment, Baseline and 52 weeks|Fasting Plasma Glucose Change From Baseline After 76 Weeks of Treatment, Fasting plasma glucose - change from baseline after 76 weeks of treatment, Baseline and 76 weeks
Sponsor/Collaborators: Sponsor: Boehringer Ingelheim | Collaborators: Eli Lilly and Company
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 2705
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2011-02
Completion Date: 2013-05
Results First Posted: 2014-07-15
Last Update Posted: 2014-07-15
Locations: 1245.31.10145 Boehringer Ingelheim Investigational Site, Birmingham, Alabama, United States|1245.31.10162 Boehringer Ingelheim Investigational Site, Glendale, Arizona, United States|1245.31.10124 Boehringer Ingelheim Investigational Site, Mesa, Arizona, United States|1245.31.10108 Boehringer Ingelheim Investigational Site, Phoenix, Arizona, United States|1245.31.10046 Boehringer Ingelheim Investigational Site, Tempe, Arizona, United States|1245.31.10154 Boehringer Ingelheim Investigational Site, Chino, California, United States|1245.31.10149 Boehringer Ingelheim Investigational Site, Rancho Cucamonga, California, United States|1245.31.10131 Boehringer Ingelheim Investigational Site, West Hills, California, United States|1245.31.10038 Boehringer Ingelheim Investigational Site, Northglenn, Colorado, United States|1245.31.10127 Boehringer Ingelheim Investigational Site, Waterbury, Connecticut, United States|1245.31.10137 Boehringer Ingelheim Investigational Site, Clearwater, Florida, United States|1245.31.10133 Boehringer Ingelheim Investigational Site, Jupiter, Florida, United States|1245.31.10006 Boehringer Ingelheim Investigational Site, Miami, Florida, United States|1245.31.10085 Boehringer Ingelheim Investigational Site, Plantation, Florida, United States|1245.31.10080 Boehringer Ingelheim Investigational Site, Decatur, Georgia, United States|1245.31.10077 Boehringer Ingelheim Investigational Site, Perry, Georgia, United States|1245.31.10001 Boehringer Ingelheim Investigational Site, Chicago, Illinois, United States|1245.31.10159 Boehringer Ingelheim Investigational Site, Des Moines, Iowa, United States|1245.31.10014 Boehringer Ingelheim Investigational Site, Dubuque, Iowa, United States|1245.31.10117 Boehringer Ingelheim Investigational Site, Arkansas City, Kansas, United States|1245.31.10157 Boehringer Ingelheim Investigational Site, Newton, Kansas, United States|1245.31.10146 Boehringer Ingelheim Investigational Site, Louisville, Kentucky, United States|1245.31.10003 Boehringer Ingelheim Investigational Site, Dearborn, Michigan, United States|1245.31.10059 Boehringer Ingelheim Investigational Site, New Hyde Park, New York, United States|1245.31.10034 Boehringer Ingelheim Investigational Site, Rochester, New York, United States|1245.31.10123 Boehringer Ingelheim Investigational Site, Smithtown, New York, United States|1245.31.10071 Boehringer Ingelheim Investigational Site, Asheboro, North Carolina, United States|1245.31.10086 Boehringer Ingelheim Investigational Site, Salisbury, North Carolina, United States|1245.31.10129 Boehringer Ingelheim Investigational Site, Carlisle, Ohio, United States|1245.31.10045 Boehringer Ingelheim Investigational Site, Cincinnati, Ohio, United States|1245.31.10119 Boehringer Ingelheim Investigational Site, Cincinnati, Ohio, United States|1245.31.10130 Boehringer Ingelheim Investigational Site, Gallipolis, Ohio, United States|1245.31.10158 Boehringer Ingelheim Investigational Site, Mount Pleasant, South Carolina, United States|1245.31.10015 Boehringer Ingelheim Investigational Site, Simpsonville, South Carolina, United States|1245.31.10033 Boehringer Ingelheim Investigational Site, Chattanooga, Tennessee, United States|1245.31.10112 Boehringer Ingelheim Investigational Site, Memphis, Tennessee, United States|1245.31.10156 Boehringer Ingelheim Investigational Site, Houston, Texas, United States|1245.31.10151 Boehringer Ingelheim Investigational Site, Hurst, Texas, United States|1245.31.10143 Boehringer Ingelheim Investigational Site, Killeen, Texas, United States|1245.31.10155 Boehringer Ingelheim Investigational Site, San Antonio, Texas, United States|1245.31.32008 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1245.31.32023 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1245.31.32003 Boehringer Ingelheim Investigational Site, De Pinte, Belgium|1245.31.32015 Boehringer Ingelheim Investigational Site, Deurne, Belgium|1245.31.32016 Boehringer Ingelheim Investigational Site, Deurne, Belgium|1245.31.32025 Boehringer Ingelheim Investigational Site, Gozée, Belgium|1245.31.32019 Boehringer Ingelheim Investigational Site, Leopoldsburg, Belgium|1245.31.32024 Boehringer Ingelheim Investigational Site, Linkebeek, Belgium|1245.31.32021 Boehringer Ingelheim Investigational Site, Mouscron, Belgium|1245.31.32020 Boehringer Ingelheim Investigational Site, Sint-Gillis-Waas, Belgium|1245.31.32018 Boehringer Ingelheim Investigational Site, Tielt, Belgium|1245.31.32026 Boehringer Ingelheim Investigational Site, Tremelo, Belgium|1245.31.20032 Boehringer Ingelheim Investigational Site, Calgary, Alberta, Canada|1245.31.20023 Boehringer Ingelheim Investigational Site, Edmonton, Alberta, Canada|1245.31.20011 Boehringer Ingelheim Investigational Site, Chilliwack, British Columbia, Canada|1245.31.20028 Boehringer Ingelheim Investigational Site, Vancouver, British Columbia, Canada|1245.31.20018 Boehringer Ingelheim Investigational Site, Victoria, British Columbia, Canada|1245.31.20033 Boehringer Ingelheim Investigational Site, Victoria, British Columbia, Canada|1245.31.20015 Boehringer Ingelheim Investigational Site, Winnipeg, Manitoba, Canada|1245.31.20012 Boehringer Ingelheim Investigational Site, Moncton, New Brunswick, Canada|1245.31.20016 Boehringer Ingelheim Investigational Site, Mount Pearl, Newfoundland and Labrador, Canada|1245.31.20024 Boehringer Ingelheim Investigational Site, Paradise, Newfoundland and Labrador, Canada|1245.31.20008 Boehringer Ingelheim Investigational Site, St. John's, Newfoundland and Labrador, Canada|1245.31.20026 Boehringer Ingelheim Investigational Site, Halifax, Nova Scotia, Canada|1245.31.20022 Boehringer Ingelheim Investigational Site, Brampton, Ontario, Canada|1245.31.20057 Boehringer Ingelheim Investigational Site, Brampton, Ontario, Canada|1245.31.20035 Boehringer Ingelheim Investigational Site, Corunna, Ontario, Canada|1245.31.20030 Boehringer Ingelheim Investigational Site, Etobicoke, Ontario, Canada|1245.31.20019 Boehringer Ingelheim Investigational Site, Hamilton, Ontario, Canada|1245.31.20017 Boehringer Ingelheim Investigational Site, London, Ontario, Canada|1245.31.20029 Boehringer Ingelheim Investigational Site, London, Ontario, Canada|1245.31.20060 Boehringer Ingelheim Investigational Site, London, Ontario, Canada|1245.31.20003 Boehringer Ingelheim Investigational Site, Markham, Ontario, Canada|1245.31.20009 Boehringer Ingelheim Investigational Site, Newmarket, Ontario, Canada|1245.31.20040 Boehringer Ingelheim Investigational Site, Oakville, Ontario, Canada|1245.31.20034 Boehringer Ingelheim Investigational Site, Sarnia, Ontario, Canada|1245.31.20005 Boehringer Ingelheim Investigational Site, Strathroy, Ontario, Canada|1245.31.20002 Boehringer Ingelheim Investigational Site, Toronto, Ontario, Canada|1245.31.20006 Boehringer Ingelheim Investigational Site, Toronto, Ontario, Canada|1245.31.20007 Boehringer Ingelheim Investigational Site, Montague, Prince Edward Island, Canada|1245.31.20027 Boehringer Ingelheim Investigational Site, Laval, Quebec, Canada|1245.31.20025 Boehringer Ingelheim Investigational Site, Montreal, Quebec, Canada|1245.31.20036 Boehringer Ingelheim Investigational Site, Sherbrooke, Quebec, Canada|1245.31.20058 Boehringer Ingelheim Investigational Site, St-Romuald, Quebec, Canada|1245.31.20021 Boehringer Ingelheim Investigational Site, Trois Rivieres, Quebec, Canada|1245.31.20038 Boehringer Ingelheim Investigational Site, Ville Saint-Laurent, Quebec, Canada|1245.31.20041 Boehringer Ingelheim Investigational Site, Saskatoon, Saskatchewan, Canada|1245.31.86007 Boehringer Ingelheim Investigational Site, Beijing, China|1245.31.86008 Boehringer Ingelheim Investigational Site, Beijing, China|1245.31.86031 Boehringer Ingelheim Investigational Site, Beijing, China|1245.31.86032 Boehringer Ingelheim Investigational Site, Beijing, China|1245.31.86033 Boehringer Ingelheim Investigational Site, Beijing, China|1245.31.86034 Boehringer Ingelheim Investigational Site, Beijing, China|1245.31.86035 Boehringer Ingelheim Investigational Site, Beijing, China|1245.31.86058 Boehringer Ingelheim Investigational Site, Chongqing, China|1245.31.86038 Boehringer Ingelheim Investigational Site, Dalian, China|1245.31.86001 Boehringer Ingelheim Investigational Site, Guangzhou, China|1245.31.86003 Boehringer Ingelheim Investigational Site, Guangzhou, China|1245.31.86052 Boehringer Ingelheim Investigational Site, Guangzhou, China|1245.31.86012 Boehringer Ingelheim Investigational Site, Guiyang, China|1245.31.86037 Boehringer Ingelheim Investigational Site, Haerbin, China|1245.31.86020 Boehringer Ingelheim Investigational Site, Hangzhou, China|1245.31.86049 Boehringer Ingelheim Investigational Site, Jinan, China|1245.31.86053 Boehringer Ingelheim Investigational Site, Jinan, China|1245.31.86018 Boehringer Ingelheim Investigational Site, Jingzhou, China|1245.31.86055 Boehringer Ingelheim Investigational Site, Nan Ning, China|1245.31.86056 Boehringer Ingelheim Investigational Site, Nan Ning, China|1245.31.86019 Boehringer Ingelheim Investigational Site, Nanchang, China|1245.31.86042 Boehringer Ingelheim Investigational Site, Nanjing, China|1245.31.86043 Boehringer Ingelheim Investigational Site, Nanjing, China|1245.31.86016 Boehringer Ingelheim Investigational Site, QingDao, China|1245.31.86039 Boehringer Ingelheim Investigational Site, Shanghai, China|1245.31.86054 Boehringer Ingelheim Investigational Site, Shantou, China|1245.31.86057 Boehringer Ingelheim Investigational Site, Shenyang, China|1245.31.86045 Boehringer Ingelheim Investigational Site, Shijiazhuang, China|1245.31.86017 Boehringer Ingelheim Investigational Site, Shiyan, China|1245.31.86013 Boehringer Ingelheim Investigational Site, Suzhou, China|1245.31.86015 Boehringer Ingelheim Investigational Site, Taiyuan, China|1245.31.86036 Boehringer Ingelheim Investigational Site, Tianjin, China|1245.31.86011 Boehringer Ingelheim Investigational Site, Xi'An, China|1245.31.86041 Boehringer Ingelheim Investigational Site, Xi'An, China|1245.31.86014 Boehringer Ingelheim Investigational Site, Xiamen, China|1245.31.33008 Boehringer Ingelheim Investigational Site, Bersée, France|1245.31.33020 Boehringer Ingelheim Investigational Site, Bischheim, France|1245.31.33002 Boehringer Ingelheim Investigational Site, Bondy Cedex, France|1245.31.33016 Boehringer Ingelheim Investigational Site, Bruay La Buissiere, France|1245.31.33001 Boehringer Ingelheim Investigational Site, Corbeil Essonnes, France|1245.31.33010 Boehringer Ingelheim Investigational Site, Croix, France|1245.31.33009 Boehringer Ingelheim Investigational Site, Hautmont, France|1245.31.33003 Boehringer Ingelheim Investigational Site, La Rochelle Cedex 1, France|1245.31.33045 Boehringer Ingelheim Investigational Site, Marseille, France|1245.31.33004 Boehringer Ingelheim Investigational Site, Narbonne Cedex, France|1245.31.33012 Boehringer Ingelheim Investigational Site, Schiltigheim, France|1245.31.33013 Boehringer Ingelheim Investigational Site, Strasbourg, France|1245.31.33019 Boehringer Ingelheim Investigational Site, Strasbourg, France|1245.31.33007 Boehringer Ingelheim Investigational Site, Vieux Condé, France|1245.31.33018 Boehringer Ingelheim Investigational Site, Wattrelos, France|1245.31.49001 Boehringer Ingelheim Investigational Site, Dormagen, Germany|1245.31.49013 Boehringer Ingelheim Investigational Site, Dresden, Germany|1245.31.49016 Boehringer Ingelheim Investigational Site, Düsseldorf, Germany|1245.31.49009 Boehringer Ingelheim Investigational Site, Flörsheim, Germany|1245.31.49015 Boehringer Ingelheim Investigational Site, Frankfurt, Germany|1245.31.49019 Boehringer Ingelheim Investigational Site, Haag, Germany|1245.31.49004 Boehringer Ingelheim Investigational Site, Hatten, Germany|1245.31.49020 Boehringer Ingelheim Investigational Site, Hohenmölsen, Germany|1245.31.49007 Boehringer Ingelheim Investigational Site, Künzing, Germany|1245.31.49002 Boehringer Ingelheim Investigational Site, Neuwied, Germany|1245.31.49008 Boehringer Ingelheim Investigational Site, Nürnberg, Germany|1245.31.49010 Boehringer Ingelheim Investigational Site, Rednitzhembach, Germany|1245.31.49006 Boehringer Ingelheim Investigational Site, Rehburg-Loccum, Germany|1245.31.49011 Boehringer Ingelheim Investigational Site, Rehlingen-Siersburg, Germany|1245.31.49005 Boehringer Ingelheim Investigational Site, Saarbrücken, Germany|1245.31.49022 Boehringer Ingelheim Investigational Site, Schauenburg, Germany|1245.31.49017 Boehringer Ingelheim Investigational Site, St. Ingbert/Oberwürzbach, Germany|1245.31.49003 Boehringer Ingelheim Investigational Site, Unterschneidheim, Germany|1245.31.30004 Boehringer Ingelheim Investigational Site, Thessaloniki, Greece|1245.31.91005 Boehringer Ingelheim Investigational Site, Bangalore, India|1245.31.91006 Boehringer Ingelheim Investigational Site, Bangalore, India|1245.31.91008 Boehringer Ingelheim Investigational Site, Bangalore, India|1245.31.91003 Boehringer Ingelheim Investigational Site, Belgaum, India|1245.31.91004 Boehringer Ingelheim Investigational Site, Chennai, India|1245.31.91009 Boehringer Ingelheim Investigational Site, Chennai, India|1245.31.91001 Boehringer Ingelheim Investigational Site, Coimbatore, India|1245.31.91101 Boehringer Ingelheim Investigational Site, Coimbatore, India|1245.31.91015 Boehringer Ingelheim Investigational Site, Gulbarga, India|1245.31.91104 Boehringer Ingelheim Investigational Site, Indore, India|1245.31.91103 Boehringer Ingelheim Investigational Site, Maharashtra, India|1245.31.91007 Boehringer Ingelheim Investigational Site, Mumbai, Maharastra, India|1245.31.91002 Boehringer Ingelheim Investigational Site, Mumbai, India|1245.31.91010 Boehringer Ingelheim Investigational Site, Nagpur, India|1245.31.91012 Boehringer Ingelheim Investigational Site, New Delhi, India|1245.31.91014 Boehringer Ingelheim Investigational Site, Pune, India|1245.31.91105 Boehringer Ingelheim Investigational Site, Pune, India|1245.31.35304 Boehringer Ingelheim Investigational Site, Birr, Co. Offaly, Ireland|1245.31.35302 Boehringer Ingelheim Investigational Site, Co. Cork, Ireland|1245.31.35305 Boehringer Ingelheim Investigational Site, Co. Galway, Ireland|1245.31.35303 Boehringer Ingelheim Investigational Site, Co. Wexford, Ireland|1245.31.35306 Boehringer Ingelheim Investigational Site, Co. Wexford, Ireland|1245.31.81007 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo, Japan|1245.31.81001 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo, Japan|1245.31.81002 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo, Japan|1245.31.81005 Boehringer Ingelheim Investigational Site, Ebetsu, Hokkaido, Japan|1245.31.81004 Boehringer Ingelheim Investigational Site, Kamakura, Kanagawa, Japan|1245.31.81003 Boehringer Ingelheim Investigational Site, Minato-ku, Tokyo, Japan|1245.31.81006 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo, Japan|1245.31.81008 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo, Japan|1245.31.81009 Boehringer Ingelheim Investigational Site, Suita, Osaka, Japan|1245.31.81010 Boehringer Ingelheim Investigational Site, Ube, Yamaguchi, Japan|1245.31.81012 Boehringer Ingelheim Investigational Site, Urasoe, Okinawa, Japan|1245.31.81013 Boehringer Ingelheim Investigational Site, Urasoe, Okinawa, Japan|1245.31.82012 Boehringer Ingelheim Investigational Site, Anyang, Korea, Republic of|1245.31.82011 Boehringer Ingelheim Investigational Site, Goyang, Korea, Republic of|1245.31.82009 Boehringer Ingelheim Investigational Site, Ilsan, Korea, Republic of|1245.31.82001 Boehringer Ingelheim Investigational Site, Incheon, Korea, Republic of|1245.31.82006 Boehringer Ingelheim Investigational Site, Jeonju, Korea, Republic of|1245.31.82004 Boehringer Ingelheim Investigational Site, Pusan, Korea, Republic of|1245.31.82005 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of|1245.31.82007 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of|1245.31.82008 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of|1245.31.82010 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of|1245.31.82014 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of|1245.31.82002 Boehringer Ingelheim Investigational Site, Suwon, Korea, Republic of|1245.31.82003 Boehringer Ingelheim Investigational Site, Wonju, Korea, Republic of|1245.31.52003 Boehringer Ingelheim Investigational Site, Guadalajara, Mexico|1245.31.52004 Boehringer Ingelheim Investigational Site, Guadalajara, Mexico|1245.31.52001 Boehringer Ingelheim Investigational Site, Monterrey, Mexico|1245.31.52002 Boehringer Ingelheim Investigational Site, Monterrey, Mexico|1245.31.63002 Boehringer Ingelheim Investigational Site, Cebu, Philippines|1245.31.63003 Boehringer Ingelheim Investigational Site, Davao City, Philippines|1245.31.63001 Boehringer Ingelheim Investigational Site, Manila, Philippines|1245.31.63004 Boehringer Ingelheim Investigational Site, Manila, Philippines|1245.31.63005 Boehringer Ingelheim Investigational Site, Manila, Philippines|1245.31.74005 Boehringer Ingelheim Investigational Site, Bratislava, Slovakia|1245.31.74002 Boehringer Ingelheim Investigational Site, Lucenec, Slovakia|1245.31.74006 Boehringer Ingelheim Investigational Site, Nitra, Slovakia|1245.31.74014 Boehringer Ingelheim Investigational Site, Nove Zamky, Slovakia|1245.31.74001 Boehringer Ingelheim Investigational Site, Povazska Bystrica, Slovakia|1245.31.74004 Boehringer Ingelheim Investigational Site, Presov, Slovakia|1245.31.74003 Boehringer Ingelheim Investigational Site, Trebisov, Slovakia|1245.31.38003 Boehringer Ingelheim Investigational Site, Celje, Slovenia|1245.31.38002 Boehringer Ingelheim Investigational Site, Koper, Slovenia|1245.31.38001 Boehringer Ingelheim Investigational Site, Maribor, Slovenia|1245.31.41004 Boehringer Ingelheim Investigational Site, Lugano, Switzerland|1245.31.41003 Boehringer Ingelheim Investigational Site, Rorschach, Switzerland|1245.31.88010 Boehringer Ingelheim Investigational Site, Kaohsiung, Taiwan|1245.31.88011 Boehringer Ingelheim Investigational Site, Kaohsiung, Taiwan|1245.31.88012 Boehringer Ingelheim Investigational Site, Kaohsiung, Taiwan|1245.31.88013 Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|1245.31.88009 Boehringer Ingelheim Investigational Site, Taichung, Taiwan|1245.31.88014 Boehringer Ingelheim Investigational Site, Tainan, Taiwan|1245.31.88006 Boehringer Ingelheim Investigational Site, Taipei, Taiwan|1245.31.88021 Boehringer Ingelheim Investigational Site, Taipei, Taiwan|1245.31.88008 Boehringer Ingelheim Investigational Site, Taoyuan County, Taiwan|1245.31.90003 Boehringer Ingelheim Investigational Site, Erzurum, Turkey|1245.31.90001 Boehringer Ingelheim Investigational Site, Gaziantep, Turkey|1245.31.90002 Boehringer Ingelheim Investigational Site, Istanbul, Turkey|1245.31.90006 Boehringer Ingelheim Investigational Site, Istanbul, Turkey|1245.31.90004 Boehringer Ingelheim Investigational Site, Izmir, Turkey|1245.31.75002 Boehringer Ingelheim Investigational Site, Dnepropetrovsk, Ukraine|1245.31.75001 Boehringer Ingelheim Investigational Site, Kharkiv, Ukraine|1245.31.75006 Boehringer Ingelheim Investigational Site, Lviv, Ukraine|1245.31.75004 Boehringer Ingelheim Investigational Site, Vinnitsa, Ukraine|1245.31.75003 Boehringer Ingelheim Investigational Site, Vinnytsya, Ukraine
URL: https://clinicaltrials.gov/show/NCT01289990

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress